Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Oct-23 10:12 AM View:  | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Grant | 170,000 | -- | -- | 45% 378.09K to 548.09K | |
| 11-Oct-23 10:12 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Disposition (change in control) | 548,087 | -- | -- | (100%) 548.09K to 0 | |
| 14-Sep-23 4:13 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 13-Sep-23 | Sale | 8,998 | $1.33 | $11,928.60 | (2%) 387.08K to 378.09K | |
| 14-Sep-23 4:13 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 12-Sep-23 | Grant | 31,200 | -- | -- | 9% 355.88K to 387.08K | |
| 09-Feb-23 5:11 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 08-Feb-23 | Payment of Exercise | 6,544 | $0.60 | $3,903.50 | (2%) 362.43K to 355.88K | |
| 09-Feb-23 5:11 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 07-Feb-23 | Grant | 22,547 | -- | -- | 7% 339.88K to 362.43K | |
| 02-Feb-23 8:08 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 01-Feb-23 | Payment of Exercise | 5,927 | $0.60 | $3,527.75 | (2%) 345.81K to 339.88K | |
| 02-Feb-23 8:08 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 31-Jan-23 | Grant | 21,073 | -- | -- | 6% 324.74K to 345.81K | |
| 25-Jan-23 5:28 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 24-Jan-23 | Grant | 170,000 | -- | -- | 110% 154.74K to 324.74K | |
| 25-Jan-23 5:28 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 23-Jan-23 | Sale | 17,769 | $0.60 | $10,622.30 | (10%) 172.5K to 154.74K | |
| 20-Jul-22 4:05 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 19-Jul-22 | Sale | 6,013 | $1.10 | $6,614.30 | (3%) 178.52K to 172.5K | |
| 20-Jul-22 4:05 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 18-Jul-22 | Grant | 20,800 | -- | -- | 13% 157.72K to 178.52K | |
| 28-Jan-22 4:18 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 26-Jan-22 | Grant | 85,000 | -- | -- | 117% 72.72K to 157.72K | |
| 25-Jan-21 4:22 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 21-Jan-21 | Grant | 52,000 | -- | -- | 251% 20.72K to 72.72K | |
| 07-Aug-18 4:28 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 06-Aug-18 | Market Purchase | 8,518 | $5.97 | $50,842.20 | 70% 12.2K to 20.72K | (41%) |
| 16-May-17 8:50 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 12-May-17 | Market Purchase | 5,200 | $19.82 | $103,064.00 | 74% 7.0K to 12.2K | (82%) |
| 08-Dec-16 2:01 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 07-Dec-16 | Market Purchase | 4,000 | $14.03 | $56,120.00 | 133% 3.0K to 7.0K | (76%) |
| 08-Dec-16 2:01 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 06-Dec-16 | Market Purchase | 3,000 | $14.15 | $42,450.00 | 100% 0 to 3.0K | (76%) |
| 06-Jun-16 5:19 PM View: | Antares Pharma Inc. (ATRS) | 02-Jun-16 | Grant | 121,050 | $1.12 | $135,576.00 | 45% 270.22K to 391.27K | 242% |
| 21-Mar-16 9:13 AM View: | Antares Pharma Inc. (ATRS) | 18-Mar-16 | Market Purchase | 135,000 | $0.72 | $97,200.00 | 100% 135.22K to 270.22K | 455% |
| 01-Jun-15 8:09 PM View: | Antares Pharma Inc. (ATRS) | 28-May-15 | Grant | 95,216 | -- | -- | 238% 40.0K to 135.22K | |
| 15-Dec-14 5:49 PM View: | Antares Pharma Inc. (ATRS) | 11-Dec-14 | Market Purchase | 40,000 | $2.49 | $99,800.00 | 100% 0 to 40.0K | 59% |
| 23-Jun-14 4:33 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Jun-14 | Payment of Exercise | 80 | $21.18 | $1,694.40 | (< 1%) 68.68K to 68.6K | (63%) |
| 20-Feb-14 5:34 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Grant | 21,375 | -- | -- | 50% 42.98K to 64.35K | |
| 20-Feb-14 5:34 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Payment of Exercise | 668 | $28.30 | $18,904.40 | (1%) 64.35K to 63.68K | (22%) |
| 11-Feb-14 9:35 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-14 | Payment of Exercise | 2,156 | $23.68 | $51,054.10 | (5%) 45.13K to 42.98K | (46%) |
| 12-Dec-13 4:05 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 11-Dec-13 | Option Exercise | 71,067 | $4.78 | $339,700.00 | 157% 45.13K to 116.2K | |
| 12-Dec-13 4:05 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 11-Dec-13 | Market Option Sale (Planned) | 71,067 | $20.37 | $1,447,450.00 | (61%) 116.2K to 45.13K | (79%) |
| 25-Jun-13 4:00 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Jun-13 | Payment of Exercise | 80 | $17.15 | $1,372.00 | (< 1%) 45.21K to 45.13K | (101%) |
| 11-Feb-13 5:26 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Grant | 19,140 | -- | -- | 72% 26.55K to 45.69K | |
| 11-Feb-13 5:26 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Payment of Exercise | 482 | $18.30 | $8,820.60 | (1%) 45.69K to 45.21K | (88%) |
| 25-Jun-12 5:01 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Jun-12 | Grant | 750 | -- | -- | 3% 25.8K to 26.55K | |
| 01-Mar-12 5:00 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 28-Feb-12 | Payment of Exercise | 1,053 | $20.07 | $21,133.70 | (4%) 26.84K to 25.79K | (72%) |
| 07-Nov-11 5:05 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 03-Nov-11 | Market Purchase | 1,610 | $15.54 | $25,024.10 | 6% 25.23K to 26.84K | 135% |
| 04-Apr-11 8:38 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 28-Feb-11 | Payment of Exercise | 941 | $22.47 | $21,144.30 | (4%) 26.19K to 25.25K | (53%) |
| 16-Mar-10 6:11 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 12-Mar-10 | Payment of Exercise | 941 | $30.20 | $28,418.20 | (3%) 27.13K to 26.19K | |
| 02-Mar-10 7:30 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 28-Feb-10 | Grant | 9,378 | -- | -- | 53% 17.75K to 27.13K | |
| 16-Sep-09 7:14 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 14-Sep-09 | Option Exercise | 4,000 | $4.78 | $19,120.00 | 23% 17.75K to 21.75K | |
| 16-Sep-09 7:14 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 14-Sep-09 | Market Option Sale (Planned) | 4,000 | $30.70 | $122,811.00 | (18%) 21.75K to 17.75K | (13%) |
| 10-Sep-09 6:37 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 08-Sep-09 | Option Exercise | 4,000 | $4.78 | $19,120.00 | 23% 17.75K to 21.75K | |
| 10-Sep-09 6:37 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 08-Sep-09 | Market Option Sale (Planned) | 4,000 | $30.00 | $120,007.00 | (18%) 21.75K to 17.75K | (15%) |
| 17-Jul-09 6:08 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 15-Jul-09 | Option Exercise | 4,000 | $4.78 | $19,120.00 | 23% 17.75K to 21.75K | |
| 17-Jul-09 6:08 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 15-Jul-09 | Market Option Sale (Planned) | 4,000 | $30.01 | $120,025.00 | (18%) 21.75K to 17.75K | (18%) |
| 17-Jun-09 6:42 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 15-Jun-09 | Option Exercise | 4,000 | $4.78 | $19,120.00 | 23% 17.75K to 21.75K | |
| 17-Jun-09 6:42 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 15-Jun-09 | Market Option Sale (Planned) | 4,000 | $27.21 | $108,839.00 | (18%) 21.75K to 17.75K | (31%) |
| 27-May-09 6:44 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 22-May-09 | Option Exercise | 4,000 | $4.78 | $19,120.00 | 23% 17.75K to 21.75K | |
| 27-May-09 6:44 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 22-May-09 | Market Option Sale (Planned) | 4,000 | $25.02 | $100,092.00 | (18%) 21.75K to 17.75K | (42%) |
| 20-May-09 7:25 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-May-09 | Payment of Exercise | 3,008 | $23.14 | $69,605.10 | (14%) 20.76K to 17.75K | (54%) |
| 20-Apr-09 6:02 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 17-Apr-09 | Option Exercise | 500 | $4.78 | $2,390.00 | 2% 20.76K to 21.26K | |
| 20-Apr-09 6:02 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 17-Apr-09 | Market Option Sale (Planned) | 500 | $25.00 | $12,500.00 | (2%) 21.26K to 20.76K | (41%) |